| Abstrakt: |
This document provides information about a clinical trial, NCT06219018, that aims to test the effectiveness of medical grade honey in treating cervical intraepithelial neoplasia (CIN). The trial will involve 60 participants with newly diagnosed CIN II and will compare the effects of medical grade honey, imiquimod, and LLETZ. The trial is not yet recruiting and is estimated to be completed by September 2027. The responsible party for the trial is Zuyderland Medisch Centrum. [Extracted from the article] |
